CDKN2A and cervical cancer: We conclude that there is a strong association between genome expression of high-risk HPV and immune expression of p16, both in cervical intraepithelial lesions as well as cervical malignancies, highlighting the significance of immunohistochemistry with p16 in cases of cervical cancer, and making p16, a surrogate marker for HPV in low resource settings.